salmeterol-fluticasone

DRUG3 trials

Sponsors

Northwestern University, Orion Corporation, Orion Pharma, Brigham and Women's Hospital

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseSleep Disorders

Phase 1

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

CompletedNCT03238482

Orion Corporation, Orion PharmaAsthma

Start: 2017-08-16End: 2017-12-19Updated: 2018-04-06

Unknown Phase

The Impact of Salmeterol-Fluticasone on Sleep in Patients With COPD

WithdrawnNCT00741767

Northwestern UniversityChronic Obstructive Pulmonary Disease, Sleep Disorders

Start: 2008-08-31End: 2012-02-29Updated: 2015-10-06

Replication of the INSPIRE Trial in Healthcare Claims Data

CompletedNCT05179512

Brigham and Women's HospitalChronic Obstructive Pulmonary Disease

Start: 2020-09-22End: 2021-08-30Updated: 2023-07-27